Molecular Detection of Circulating Cancer Cells: Role in Diagnosis, Prognosis and Follow-Up of Colon Cancer Patients

Digestive Diseases

Volumn 21, Issue 4, 2003, Pages 320-325

  Molnar, Bela ^a,c   Sipos, Ferenc ^b   Galamb, Orsolya ^b   Tulassay, Zsolt ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c NONE   (Hungary)

Author keywords

Chemosensitivity; Circulating cancer cells; Circulating tumor cells; Colon cancer; Colorectal cancer; Molecular biology

Indexed keywords

BLOOD ANALYSIS; BONE MARROW; CANCER CELL; CELL COUNT; COLORECTAL CANCER; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

BONE MARROW; COLONIC NEOPLASMS; DNA METHYLATION; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MICROSCOPY, FLUORESCENCE; NEOPLASM CIRCULATING CELLS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 1142310557     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075355     Document Type: Review

References (48)

1. Tiersch K: Der Epithelialkrebs, namentlich der Haut. Leipzig, 1865.
2. Paget S: Distribution of secondary growths in cancer of the breast. Lancet 1889;i:571-573.
3. Liotta LA, Kleinerman J, Saifedel GM: The significance of hematogenous tumour cell clumps in the metastatic process. Cancer Res 1976;36:889-894.
4. Glaves D: Correlation between circulating tumour cancer cells and incidence of metastases. Br J Cancer 1984;50:159-166.
5. Lindemann F, Schlimok G, Dirschedl G, et al: Prognostic significance of micrometastasic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;41:685-689.
6. Soeth E, Vogel I, Röder C, et al: Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997;57:3106-3110.
7. Martin VM, Siewert C, Scharl A, et al: Immunomagnetic enrichment of disseminated epithelial tumour cells from peripheral blood by MACS. Exp Hematol 1998;26:252-264.
8. Racila E, Euhus D, Wiess A, et al: Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-4594.
9. Stosiek P, Kasper M, Karsten U, et al: Detection of cancer in regional lymph nodes: Comparative histological and immunohistological investigations with the broad range anticytokeratin monoclonal antibody A45-B/b3. Neoplasma 1991;38:43-47.
10. Soeth E, Röder C, Juhl H, et al: The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptasepyolmerase-chain reaction is related to the stage of the disease. Int J Cancer 1996;69:278-282.
11. Molnar B, Ladányi A, Tanko L, et al: Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 2001;7:4080-4085.
12. Greenson JK, Craig EI, Rice R, et al: Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563-569.
13. Rosenberg R, Hoos A, Mueller J, Baier P, et al: Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node negative colorectal cancer patients. J Clin Oncol 2003;20:1049-1055.
14. Miltenyi S, Müller W, Weichel W, et al: High gradient magnetic cell separation with MACS. Cytometry 1990;11:231-240.
15. Moll R, Franke WW, Schiller DL, et al: The catalogue of human cytokeratins: Pattern of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
16. Wyld DK, Selby P, Perren TJ, et al: Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 1998;79:288-294.
17. Silva JM, Rodriguez R, Garcia JM, Munoz C, Silva J, Dominguez G, Provencio M, Espana P, Bonilla F: Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 2002;50:530-534.
18. Hardingham JE, Hewett PJ, Sage RE, et al: Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 2000;89:8-13.
19. Carrithers SL, Barber MT, Biswas S, et al: Guanylil cyclase C is a selective marker for metastatic colorectal tumors in human gastrointestinal tissues. Proc Natl Acad Sci USA 1996;93:13827-14832.
20. Miura M, Ichikawa Y, Tanaka K, et al: Realtime PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients. Anticancer Res 2003;23:1271-1276.
21. Park S, Lee B, Kim I, et al: Immunobead RT-PCR versus regular RT-PCR amplification of CEA mRNA in peripheral blood. J Cancer Res Clin Oncol 2001;127:489-494.
22. Soria JC, Guthier LR, Raymond E, et al: Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5:971-975.
23. Ladányi A, Soong R, Tabiti K, et al: Quantitative reverse transcription-PCR: Comparison of tumor cell enrichment methods. Clin Chem 2001;47:1860-1863.
24. Mehes G, Ambros PF, Gadner H: Detecting disseminated solid tumor cells in hematopoietic samples: Methodological aspects. Hematologia 2001;31:91-109.
25. Kraeft S, Sutherland R, Gravelin L, et al: Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system. Clin Cancer Res 2000;6:434-442.
26. Fava TA, Desnuyers R, Schulz S, et al: Ectopic expression of guanylil cyclase C in C D34+ progenitor cells in peripheral blood. J Clin Oncol 2001;19:3951-3959.
27. Ko Y, Grünewald E, Totzke G, et al: High percentage of false positive results of cytokeratin 20 RT-PCR in blood: A model for the analysis of illegitimate gene expression. Oncology 2000;59:81-88.
28. Dimmler A, Gerhards R, Betz C, et al: Transcription of cytokeratins 8,18,19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: Inherent limitations for RT-PCR in the detection of isolated tumor cells. Lab Invest 2001;81:1351-1361.
29. Molnar B, Ladányi A, Tanko L, et al: Correspondence re: Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 2002;8:2016-2017.
30. Wharton RQ, Jonas SK, Glover C, et al: Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 1999;5:4158-4163.
31. Vlems F, Soong R, Diepstra H, et al: Effect of blood sample handling and RT-PCR assay sensitivity on detection of cytokeratin 20 expression in healthy donor blood. Diagnostic Mol Pathol 2002;11:90-97.
32. Vlems F, Ladányi A, Gertler R, et al: Reliability of quantitative RT-PCR based detection of tumor cells in the blood between different laboratories using a standardized protocol. Eur J Cancer 2003;39:388-396.
33. Ito H, Hatori M, Kinugasa Y, Irie T, et al: Comparison of the expression profile of metastasis associated genes between primary and circulating cancer cells on oral squamous cell carcinoma. Anticancer Res 2003;23:1425-1431.
34. Kanyama Y, Hibi K, Nakayama H, et al: Detection of p16 promoter hypermethylation in serum of gastric cancer patients. Cancer Sci 2003;94:418-420.
35. Wong IHN: Methylation profiling of human cancers in blood: Molecular monitoring and prognostication. Intl J Oncol 2001;19:1319-1324.
36. Esteller M, Herman JG: Cancer as an epigenetic disease: DNa methylation and chromatin alterations in human tumours. J Pathol 2002;196:1-7.
37. MacDonald JS: Advances in staging and treatment of colorectal cancer. Am Soc of Clin Oncol, 36th Meeting, May 22, 2000.
38. Choi H, Choi Y, Hong S: Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum 2003;45:750-756.
39. Öberg A, Stenling R, Tavelin B, Lindmark G: Are lymph node micrometastases of any clinical significance in Dukes stage A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-1249.
40. Soong R, Beyser K, Basten O, et al: Quanitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin Cancer Res 2001;7:3423-3429.
41. Schlimok G, Funke I, Holzmann B, et al: Micrometastatic cancer cells in bone marrow: In vitro detection with anticytokeratin and invivo labeling with anti17-1A monoclonal antibodies. Proc Natl Acad Sci USA 1987;84:8672-8676.
42. Werther K, Normark M, Vrunner N, et al: Cytokeratin-positive cells in preoperative peripheral blood and bone marrow aspirates of patients with colorectal cancer. Scand J Lab Invest 2002;62:49-58.
43. Weihrauch MR, Skibowski E, Koslowsky TC, et al: Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: Correlation with established clinical parameters. J Clin Oncol 2003;21:4338-4343.
44. Leather AJM, Gallegos NC, Kocjan G, et al: Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 1993;80:777-780.
45. Patel H, Le Marer N, Wharton R, et al: Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg 2002;235:226-231.
46. Aquino A, Prete SP, Balduzzi A, et al: A novel method for monitoring response to chemotherapy based on the detection of circulating tumor cells: A case report. J Chemother 2002;14:412-416.
47. Hegewisch-Becker S, Braun K, Otte M, et al: Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies. Clin Cancer Res 2003;9:2079-2084.
48. Seufferlein T, Adler G: Gastrointestinal cancer: Towards a tailored tumour therapy. Scand J Gastroenterol 2003;38:22-25.